175 related articles for article (PubMed ID: 37301844)
1. The pediatric leukemia oncoprotein NUP98-KDM5A induces genomic instability that may facilitate malignant transformation.
Domingo-Reinés J; Montes R; Garcia-Moreno A; Gallardo A; Sanchez-Manas JM; Ellson I; Lamolda M; Calabro C; López-Escamez JA; Catalina P; Carmona-Sáez P; Real PJ; Landeira D; Ramos-Mejia V
Cell Death Dis; 2023 Jun; 14(6):357. PubMed ID: 37301844
[TBL] [Abstract][Full Text] [Related]
2. Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities.
Cardin S; Bilodeau M; Roussy M; Aubert L; Milan T; Jouan L; Rouette A; Laramée L; Gendron P; Duchaine J; Decaluwe H; Spinella JF; Mourad S; Couture F; Sinnett D; Haddad É; Landry JR; Ma J; Humphries RK; Roux PP; Hébert J; Gruber TA; Wilhelm BT; Cellot S
Blood Adv; 2019 Nov; 3(21):3307-3321. PubMed ID: 31698461
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic insights into chromatin targeting by leukemic NUP98-PHF23 fusion.
Zhang Y; Guo Y; Gough SM; Zhang J; Vann KR; Li K; Cai L; Shi X; Aplan PD; Wang GG; Kutateladze TG
Nat Commun; 2020 Jul; 11(1):3339. PubMed ID: 32620764
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive molecular and clinical characterization of
Bertrums EJM; Smith JL; Harmon L; Ries RE; Wang YJ; Alonzo TA; Menssen AJ; Chisholm KM; Leonti AR; Tarlock K; Ostronoff F; Pogosova-Agadjanyan EL; Kaspers GJL; Hasle H; Dworzak M; Walter C; Muhlegger N; Morerio C; Pardo L; Hirsch B; Raimondi S; Cooper TM; Aplenc R; Gamis AS; Kolb EA; Farrar JE; Stirewalt D; Ma X; Shaw TI; Furlan SN; Brodersen LE; Loken MR; Van den Heuvel-Eibrink MM; Zwaan CM; Triche TJ; Goemans BF; Meshinchi S
Haematologica; 2023 Aug; 108(8):2044-2058. PubMed ID: 36815378
[TBL] [Abstract][Full Text] [Related]
5. The clinical and biological characteristics of NUP98-KDM5A in pediatric acute myeloid leukemia.
Noort S; Wander P; Alonzo TA; Smith J; Ries RE; Gerbing RB; Dolman MEM; Locatelli F; Reinhardt D; Baruchel A; Stary J; Molenaar JJ; Stam RW; van den Heuvel-Eibrink MM; Zwaan MC; Meshinchi S
Haematologica; 2021 Feb; 106(2):630-634. PubMed ID: 32381579
[No Abstract] [Full Text] [Related]
6. Expression of Leukemia-Associated Nup98 Fusion Proteins Generates an Aberrant Nuclear Envelope Phenotype.
Fahrenkrog B; Martinelli V; Nilles N; Fruhmann G; Chatel G; Juge S; Sauder U; Di Giacomo D; Mecucci C; Schwaller J
PLoS One; 2016; 11(3):e0152321. PubMed ID: 27031510
[TBL] [Abstract][Full Text] [Related]
7. CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia.
Schmoellerl J; Barbosa IAM; Eder T; Brandstoetter T; Schmidt L; Maurer B; Troester S; Pham HTT; Sagarajit M; Ebner J; Manhart G; Aslan E; Terlecki-Zaniewicz S; Van der Veen C; Hoermann G; Duployez N; Petit A; Lapillonne H; Puissant A; Itzykson R; Moriggl R; Heuser M; Meisel R; Valent P; Sexl V; Zuber J; Grebien F
Blood; 2020 Jul; 136(4):387-400. PubMed ID: 32344427
[TBL] [Abstract][Full Text] [Related]
8. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
[TBL] [Abstract][Full Text] [Related]
9. The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML.
Heikamp EB; Henrich JA; Perner F; Wong EM; Hatton C; Wen Y; Barwe SP; Gopalakrishnapillai A; Xu H; Uckelmann HJ; Takao S; Kazansky Y; Pikman Y; McGeehan GM; Kolb EA; Kentsis A; Armstrong SA
Blood; 2022 Feb; 139(6):894-906. PubMed ID: 34582559
[TBL] [Abstract][Full Text] [Related]
10. Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation.
Chandra B; Michmerhuizen NL; Shirnekhi HK; Tripathi S; Pioso BJ; Baggett DW; Mitrea DM; Iacobucci I; White MR; Chen J; Park CG; Wu H; Pounds S; Medyukhina A; Khairy K; Gao Q; Qu C; Abdelhamed S; Gorman SD; Bawa S; Maslanka C; Kinger S; Dogra P; Ferrolino MC; Di Giacomo D; Mecucci C; Klco JM; Mullighan CG; Kriwacki RW
Cancer Discov; 2022 Apr; 12(4):1152-1169. PubMed ID: 34903620
[TBL] [Abstract][Full Text] [Related]
11. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.
Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Pratcorona M; Abbas S; Kuipers JE; van Galen JF; Beverloo HB; Sonneveld E; Kaspers GJ; Trka J; Baruchel A; Zimmermann M; Creutzig U; Reinhardt D; Pieters R; Valk PJ; Zwaan CM
Blood; 2011 Sep; 118(13):3645-56. PubMed ID: 21813447
[TBL] [Abstract][Full Text] [Related]
12. A cryptic translocation leading to NUP98-PHF23 fusion in AML.
Ning Y
Best Pract Res Clin Haematol; 2016 Dec; 29(4):320-323. PubMed ID: 27890253
[TBL] [Abstract][Full Text] [Related]
13. NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis.
Struski S; Lagarde S; Bories P; Puiseux C; Prade N; Cuccuini W; Pages MP; Bidet A; Gervais C; Lafage-Pochitaloff M; Roche-Lestienne C; Barin C; Penther D; Nadal N; Radford-Weiss I; Collonge-Rame MA; Gaillard B; Mugneret F; Lefebvre C; Bart-Delabesse E; Petit A; Leverger G; Broccardo C; Luquet I; Pasquet M; Delabesse E
Leukemia; 2017 Mar; 31(3):565-572. PubMed ID: 27694926
[TBL] [Abstract][Full Text] [Related]
14. The role of Nup98 in transcription regulation in healthy and diseased cells.
Franks TM; Hetzer MW
Trends Cell Biol; 2013 Mar; 23(3):112-7. PubMed ID: 23246429
[TBL] [Abstract][Full Text] [Related]
15. RNA export factor RAE1 contributes to NUP98-HOXA9-mediated leukemogenesis.
Funasaka T; Nakano H; Wu Y; Hashizume C; Gu L; Nakamura T; Wang W; Zhou P; Moore MA; Sato H; Wong RW
Cell Cycle; 2011 May; 10(9):1456-67. PubMed ID: 21467841
[TBL] [Abstract][Full Text] [Related]
16. PKR inhibits the DNA damage response, and is associated with poor survival in AML and accelerated leukemia in NHD13 mice.
Cheng X; Byrne M; Brown KD; Konopleva MY; Kornblau SM; Bennett RL; May WS
Blood; 2015 Sep; 126(13):1585-94. PubMed ID: 26202421
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of the NUP98-CCDC28A fusion protein.
Petit A; Ragu C; Soler G; Ottolenghi C; Schluth C; Radford-Weiss I; Schneider-Maunoury S; Callebaut I; Dastugue N; Drabkin HA; Bernard OA; Romana S; Penard-Lacronique V
Haematologica; 2012 Mar; 97(3):379-87. PubMed ID: 22058212
[TBL] [Abstract][Full Text] [Related]
18. NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy.
Roussy M; Bilodeau M; Jouan L; Tibout P; Laramée L; Lemyre E; Léveillé F; Tihy F; Cardin S; Sauvageau C; Couture F; Louis I; Choblet A; Patey N; Gendron P; Duval M; Teira P; Hébert J; Wilhelm BT; Choi JK; Gruber TA; Bittencourt H; Cellot S
Genes Chromosomes Cancer; 2018 Jun; 57(6):311-319. PubMed ID: 29427526
[TBL] [Abstract][Full Text] [Related]
19. Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia.
Jankovic D; Gorello P; Liu T; Ehret S; La Starza R; Desjobert C; Baty F; Brutsche M; Jayaraman PS; Santoro A; Mecucci C; Schwaller J
Blood; 2008 Jun; 111(12):5672-82. PubMed ID: 18388181
[TBL] [Abstract][Full Text] [Related]
20. NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia.
Shiba N; Ichikawa H; Taki T; Park MJ; Jo A; Mitani S; Kobayashi T; Shimada A; Sotomatsu M; Arakawa H; Adachi S; Tawa A; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Hayashi Y
Genes Chromosomes Cancer; 2013 Jul; 52(7):683-93. PubMed ID: 23630019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
